Despite significant progress, incorporating genetic data into clinical trials still presents many challenges for sponsors working on therapies for rare diseases. This is especially due to concerns of patient identification and enrollment, guidelines around use of genetic test results, and more.
In this webinar, originally presented with FierceBiotech, Karmen Trzupek, M.S., CGC, Director of Rare Disease Genetics Services and Clinical Trial Services at InformedDNA, explores how to address and overcome challenges in genetics-based clinical trials. Topics include the following, with case studies addressing each:
- Effective patient identification
- Strengthening patient engagement and retention
- Collection, use, and disclosure of genetic data
- Planning for a successful post-market environment
Who should watch this webinar? Anyone involved in designing or operating clinical trials for rare disease therapies.
InformedDNA is the authority on the appropriate use of genetic testing. Key offerings for sponsors and CROs include support for rare disease clinical trial design; patient recruitment, enrollment and engagement; physician engagement; clinical genetic counseling; and, test facilitation and interpretation services. If you have questions or would like to chat, email us at pharma@54.152.200.188; or, call us at 844-846-3763.
